Pilgrim Sensor Scores a Breakthrough $25M From Anthropic
Quick Reads
- Pilgrim biothreat sensor closed a $25 million seed round at a $150 million valuation.
- Buckley Ventures led the round, with Peter Thiel and Fred Ehrsam joining.
- Anthropic’s Logan Graham and Sholto Douglas also invested in the startup.
- Its 50-pound Argus device pairs air sampling with genomic sequencing to spot pathogens.
- Pilgrim has a CDC agreement and has begun deploying Argus units nationwide.
Pilgrim biothreat sensor technology just won a $25 million seed round at a $150 million valuation. Buckley Ventures led the round, according to the Wall Street Journal. Two Anthropic leaders joined the investor list, alongside Peter Thiel and Coinbase co-founder Fred Ehrsam. Logan Graham, who heads Anthropic’s Frontier Red Team, and technical staff member Sholto Douglas both backed the startup.
The startup builds Argus, a 50-pound device that pairs air sampling with genomic sequencing. Argus targets airborne pathogens, including Ebola and anthrax. Pilgrim has also signed an agreement with the US Centers for Disease Control and Prevention. That deal covers an automated airborne biosurveillance system. Meanwhile, the company has already started deploying Argus units across the country.
Founder Jake Adler says Pilgrim has raised more than $30 million in total funding. He also says the company wants to bring advanced biotechnology into defense and national security work.
The Anthropic link makes this round stand out. The Frontier Red Team probes what frontier AI models could enable in areas like biology, as AI Weekly explains. Now two senior members of that group are backing early-warning hardware for exactly that class of threat. Notably, the WSJ places the investment against growing fears that AI could enable new biological threats.
For now, the Pilgrim biothreat sensor still has open questions attached. Reports do not disclose the CDC contract size, the number of shipped units, or the installation sites.
